Clinical Care and Research Division

When a patient is diagnosed with HIV/AIDS or another chronic viral disorder, they want the very best in treatment options. At the Institute of Human Virology, the Clinical Care and Research Division specializes in the treatment of HIV/AIDS and other complicated infectious diseases, such as Hepatitis C, Hepatitis B, and the Human Papilloma Virus Infection. Patients get the very best in care from physicians who specialize in chronic viral disorders and virally linked cancers.

The Clinical Care and Research Division also is committed to providing a state-of-the-art clinical trials program that offers patients the latest in scientific breakthroughs and helps advance the understanding and management of HIV/AIDS and its complications. This commitment is carried out by an accomplished team of multidisciplinary personnel dedicated to the pursuit of excellence in both clinical care and clinical research.

In addition, the Division has in only a very short time advanced several new concepts in potential AIDS therapies and therapeutic vaccines from concept into the clinic.

"The IHV's physicians and scientists are world-renowned for their expertise in HIV/AIDS and other chronic viral disorders," says Dr. Robert Redfield, director of the Clinical Care and Research Division. "And we work closely with the Institute's Basic Science, Vaccine Development and Epidemiology and Prevention divisions to accelerate the pace of scientific discovery. This feature, unique to the IHV, benefits patients locally and the scientific community globally."

In Baltimore, patients have access to six separate clinics staffed by IHV professionals and an assortment of patient support groups to help them better cope with their disease and are able to participate in a full spectrum of clinical research opportunities conducted by the Institute's Clinical Research Unit.

"Therapeutic advances in the treatment of HIV/AIDS is transforming what used to be a rapidly fatal disease to a chronic disorder that can be successfully managed for several decades," says Dr. Redfield. "The Institute works daily to provide patients with the latest in quality care and constantly strives for continued progress that will benefit those diagnosed with the disease worldwide."